Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Kanemoto

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Patient Safety|August 15, 2015
Frequency and Severity of Adverse Drug Events by Medication Classes: The JADE StudyMio Sakuma, Yuko Kanemoto, Akari Furuse, et al.
International Journal of Molecular Sciences|December 17, 2024
A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and ChemoresistanceYasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, et al.
Biomolecules|September 28, 2024
Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast CancerYuko Kanemoto, Fumihiro Sanada, Kana Shibata, et al.
Cells|September 14, 2024
The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and CancerKana Shibata, Nobutaka Koibuchi, Fumihiro Sanada, et al.
Cancers|October 23, 2021
Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and AngiogenesisTatsuya Fujikawa, Fumihiro Sanada, Yoshiaki Taniyama, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Patient Safety|August 15, 2015
Frequency and Severity of Adverse Drug Events by Medication Classes: The JADE StudyMio Sakuma, Yuko Kanemoto, Akari Furuse, et al.
International Journal of Molecular Sciences|December 17, 2024
A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and ChemoresistanceYasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, et al.
Biomolecules|September 28, 2024
Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast CancerYuko Kanemoto, Fumihiro Sanada, Kana Shibata, et al.
Cells|September 14, 2024
The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and CancerKana Shibata, Nobutaka Koibuchi, Fumihiro Sanada, et al.
Cancers|October 23, 2021
Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and AngiogenesisTatsuya Fujikawa, Fumihiro Sanada, Yoshiaki Taniyama, et al.
Pageof 1